FDA — authorised 4 February 2004
- Application: NDA021462
- Marketing authorisation holder: LILLY
- Local brand name: ALIMTA
- Indication: POWDER — INTRAVENOUS
- Status: approved
🇺🇸 paclitaxel poliglumex, pemetrexed in United States
FDA authorised paclitaxel poliglumex, pemetrexed on 4 February 2004
Marketing authorisation
Frequently asked questions
Is paclitaxel poliglumex, pemetrexed approved in United States?
Yes. FDA authorised it on 4 February 2004.
Who is the marketing authorisation holder for paclitaxel poliglumex, pemetrexed in United States?
LILLY holds the US marketing authorisation.